ResMed Inc. (RMD) stock analysis

Healthcare · Medical Instruments & Supplies

From the 10-K filed 2026-08-13

Business type: Franchise

How it makes money

Clinicians and patients use connected software and devices, while increasing health awareness drives growth.

The company provides cloud-based applications and medical devices to help clinicians manage patients and encourage therapy adherence.

Growth is further fueled by an increasing awareness of breathing health conditions.

What protects it: the moat

Management claims its AI-powered digital health solutions and cloud-connected devices create a competitive advantage.

The company asserts that its intelligent software and connected devices make home healthcare more personalized and effective.

What growth costs

It reinvests in research and development and through acquisitions to grow.

During fiscal year 2026, it invested $378 million on research and development activities, which represents 6.7% of net revenues. It also grows through acquisitions like Noctrix Health and VirtuOx.

What could damage it

Changes in how insurance companies reimburse customers could permanently reduce its sales and pricing power.

If government or private insurance plans stop adequately reimbursing patients and providers for these products, it could force a reduction in sales or prices.

About ResMed Inc.

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

More on RMD

Other companies in Medical Instruments & Supplies